Nontuberculous mycobacteria (NTM) are essentially ubiquitous and can infect both immunocompetent and immunocompromised hosts. However, NTM infection is surprisingly uncommon in reports from allogeneic hematopoietic stem cell transplant (alloSCT) centers that do not routinely perform allograft T-cell depletion. We reviewed medical records for all adult patients who underwent alloSCT at our center between January 1993 and December 2001. American Thoracic Society and Centers for Disease Control and Prevention guidelines Were used to define definite, probable, and possible NTM infection. Of 571 patients, 36 of 372 (9.7%) T-cell depleted and 14 of 199 (7.0%) conventional alloSCT recipients (P ¼ 0.26) had a positive culture for NTM after alloSCT. Of the 50 patients with NTM infection, 16 had definite infection and 34 had probable or possible infection. Rates of NTM infection were 5 to 20-fold higher than rates reported by other centers. Of the 16 definite infections, nine were caused by Mycobacterium haemophilum. Two patients had disseminated M. avium complex (MAC) infection and one had a vascular catheter infected by MAC. Three patients died from complications of NTM infection. Patients with probable or possible NTM infection had markedly different epidemiology, risk factors, site and species of NTM infection, and prognosis than patients with definite NTM infection.
Allogeneic hematopoietic stem cell transplant (alloSCT) recipients are profoundly immunocompromised, and can develop infections caused by a wide variety of organisms. Both Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM) are well-described pathogens in alloSCT recipients. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] However, distinguishing infection from colonization by NTM such as Mycobacterium avium complex (MAC) can be difficult, as infection by organisms other than NTM and noninfectious conditions such as graft-versus-host disease (GvHD) can mimic NTM infection in alloSCT recipients. Formal diagnostic criteria for NTM infection ( Figure 1 ) have been established by the Centers for Disease Control and Prevention (CDC) and the American Thoracic Society but remain controversial. 9, 21 Two comprehensive reviews of NTM infection among alloSCT recipients have been published, 9, 12 both from centers that primarily perform conventional (ie, T-cell replete) transplants. In these reviews, NTM infection was rare, occurring in only 0.37 and 0.40% of patients. We describe the epidemiology of mycobacterial infection among adult alloSCT recipients at our institution, where approximately two-thirds of allografts are T-cell depleted.
Methods
Memorial Sloan-Kettering Cancer Center (MSKCC) is a tertiary-care cancer center in New York City. Medical records were reviewed to identify all patients at least 18 years old who underwent an initial alloSCT at MSKCC between January 1993 and December 2001. T-cell depletion was performed on bone marrow or peripheral blood stem cells by either soybean agglutination followed by rosetting with sheep red blood cells, 22 T 10 B 9 -1A3, 23 or Isolex 300i (Nexell Therapeutics, Irvine, CA, USA) followed by rosetting with sheep red blood cells.
Microbiology laboratory records were reviewed to identify patients with a positive mycobacterial culture during the study period. CDC and American Thoracic Society criteria ( Figure 1 ) were used to define NTM infection. 9, 21 Mycobacteria specimens were stained with the auramine acid-fast stain and cultured on Middlebrook 7H11 agar. In addition to conventional incubation, all mycobacteria specimens were evaluated for M. haemophilum using X-factor strips (Becton Dickinson Microbiology Systems) and incubated at 301C in a 10% CO 2 atmosphere for 6 weeks. Isolates were identified by conventional growth and biochemical characteristics.
Results
Over the 9 year study period, 577 adults underwent an initial alloSCT. A total of 56 (9.7%) of the 577 alloSCT recipients had a positive culture for NTM. Six patients had their first positive culture prior to alloSCT and were excluded from further analysis. Of the remaining 571 patients, 36/372 (9.7%) T-cell depleted and 14/199 (7.0%) conventional alloSCT recipients (P ¼ 0.26) had a positive culture for NTM after alloSCT.
Definite cases of NTM infection
In total, 16 (2.8%) of 571 patients developed definite NTM infection after alloSCT, including 12/372 (3.3%) T-cell depleted and 4/199 (2.1%) conventional alloSCT recipients (P ¼ 0.37). The 16 cases are described in Table 1 . All 16 patients satisfied CDC criteria (Figure 1 ) for NTM infection, with two exceptions. Patient #15 developed pulmonary infiltrates 3 months after alloSCT. Four sputum specimens taken over 69 days grew M. abscessus. He never underwent lung biopsy. His pulmonary infiltrates resolved on antibiotic treatment for M. abscessus. The second patient (#8) developed pulmonary infiltrates 30 days after alloSCT. The patient was treated with broad-spectrum antibiotics including ciprofloxacin. An open lung biopsy showed noncaseating granulomas but all stains for organisms and cultures were negative. Two sputum specimens grew MAC and all pulmonary infiltrates resolved with antibiotics directed against MAC. All six cases of pulmonary NTM infection satisfied American Thoracic Society criteria (Figure 1) .
The median age of the 16 patients was 36.0 years and half were male. In total, 11 (68.8%) of 16 had related donors, 15/16 (93.8%) had HLA-identical (ie 6/6 HLA match) donors, 0/16 had known underlying pulmonary disease and 1/16 (patient #10) had received chest irradiation prior to the alloSCT conditioning regimen. Two patients died before NTM infection was diagnosed. The remaining 14 were treated for NTM infection. In total, 4/16 (25%) patients died from complications of NTM infection.
Nine (56.3%) of the 16 patients had definite M. haemophilum infection. Details regarding these patients have been previously published. 6 All nine received total body irradiation (TBI), chemotherapy, and an allograft depleted of T-cells by soybean agglutination and sheep red blood cell rosetting. Eight of the nine patients also received antithymocyte globulin (ATG). All six patients with M. haemophilum infection limited to the skin had HLAmatched sibling donors and were cured of M. haemophilum infection with antibiotics.
Of the other three patients with M. haemophilum infection, the first (patient #4) developed pulmonary infiltrates 4 months after alloSCT. A lung biopsy showed non-necrotizing, granulomatous pneumonitis and grew M. haemophilum. He died 16 days later from respiratory failure. The second patient (#14) remained transfusion dependent after alloSCT for aplastic anemia. EBV lymphoproliferative disease of the piriform sinus developed 3 months after alloSCT and responded to donor-derived EBV-specific lymphocytes. After 2 months, the patient presented with septic arthritis of the left elbow. Purulent fluid aspirated from the joint grew M. haemophilum. A bone marrow biopsy performed after 3 months of ethambutol, doxycycline, and ciprofloxacin for M. haemophilum infection showed noncaseating granulomas and grew MAC. Antibiotics were adjusted to treat both M. haemophilum and MAC. The elbow swelling and pain resolved over the next 4 months, and subsequent bone marrow biopsies had no granulomas and were culture negative. The final patient (#9) presented 167 days after alloSCT with septic shock. Despite broad-spectrum antibiotics, the patient died 12 days later. Blood cultures from the patient's mediport grew M. haemophilum and M. fortuitum.
Two patients had disseminated MAC infection after alloSCT. The first (patient #10) developed hepatitis and pulmonary nodules 3 months after a nonmyeloablative alloSCT. Lung and liver biopsies showed noncaseating granulomas. Cultures from a lung biopsy, blood, and sputum grew MAC. Mycobacterial susceptibility testing (National Jewish Hospital, Denver, CO, USA) confirmed susceptibility to clarithromycin. The patient's CD4 count was 315/ml and measures of in vitro T-cell proliferation and IFN-g production to antigens and mitogens such as phytohemagglutinin were normal. Despite combination antibiotic therapy including clarithromycin, ethambutol, rifampin, amikacin, clofazamine, and moxifloxacin, multiple repeat cultures from the blood and sputum over a 5-month period grew MAC. The patient's mediport was therefore removed and a culture of the tip grew MAC. All subsequent blood and sputum cultures performed since mediport removal have been negative. The patient required discontinuation of all antibiotics 1 month after mediport removal because of medication-related hepatitis but has continued to clinically improve.
The second patient (#13) remained thrombocytopenic and never recovered T-cell function after alloSCT. The post-transplant course was complicated by a wasting syndrome and transaminitis. At 8 months after alloSCT, prednisone was started for possible GVHD after a liver biopsy was nondiagnostic. Within 2 weeks, the patient developed profuse diarrhea and stool cultures were positive for MAC. Cultures from the liver biopsy eventually grew MAC as did blood and bone marrow cultures. The wasting syndrome and thrombocytopenia improved and subsequent cultures were negative after initiating treatment with clarithromycin, ethambutol, and moxifloxacin.
Probable and possible NTM infection
A total of 34 additional patients had positive cultures for NTM after alloSCT. Of the 34 patients, 12 satisfied American Thoracic Society criteria for pulmonary NTM infection and had 'probable infection' according to CDC criteria ( Figure 1 ). All 12 had positive cultures for MAC from the respiratory tract and two also had positive stool cultures for MAC. Five of the 12 had underlying lung disease including bronchiolitis obliterans (n ¼ 1), chronic obstructive pulmonary disease (n ¼ 3), and sarcoidosis (n ¼ 1). All 12 patients had received TBI as part of their conditioning regimen and 10 (83.3%) received a T-cell 
Survival among patients with NTM
Kaplan-Meier survival curves for patients with positive NTM cultures and all patients who underwent alloSCT at MSKCC are included in Figure 2 . Survival was significantly better among patients with definite NTM infection than patients with probable or possible NTM infection after alloSCT (P ¼ 0.02) (Figure 2a ) and after first positive NTM culture (Po0.03) (Figure 2b ). Among patients with definite NTM infection, survival differed significantly by site of infection (Po0.04) (Figure 2c ) but not by NTM species (P ¼ 0.23).
NTM prior to allogeneic stem cell transplant
All six patients with positive cultures for NTM prior to alloSCT had MAC and their first cultures were collected 81, 92, 98, 128, 154, and 182 days before alloSCT. Five of the six grew MAC from respiratory specimens and one patient had multiple positive urine cultures. Two patients were treated for NTM infection prior to, during, and after alloSCT. Another patient, who was not treated for a positive culture for MAC from a lung biopsy prior to alloSCT, became smear and culture positive for MAC in the stool 4 months after alloSCT, then received treatment. None of the other five patients had positive cultures for NTM after alloSCT. Five of the six patients died 23, 70, 79, 147, and 207 days after alloSCT from causes unrelated to MAC. One remaining patient (who was never treated for MAC) is alive with no evidence of MAC infection.
Discussion
NTM including MAC are essentially ubiquitous and propagate in soil, dust, and water supplies up to 511C. 21, 24 Despite their pathogenicity among a wide variety of hosts, NTM are uncommon pathogens in alloSCT recipients according to published reports. 8, 9, 12, 15, 25 Table 2 includes a comparison of the patients reported here and those from other series. The rates of positive cultures for NTM and NTM infection were 5-to 20-fold higher at our institution than at other centers.
There are several possible explanations for the high rates of NTM in our series; the first specifically involves M. haemophilum. To date, 113 patients with M. haemophilum infection have been described worldwide. In all, 23 (20.4%) cases have occurred at MSKCC, 3, 6 including the nine patients described above. The first two MSKCC cases were part of a multicenter 1990-1991 cluster of M. haemophilum infections in the New York City area. 26 An extensive investigation performed in collaboration with the CDC failed to elucidate a source of M. haemophilum at our center or elsewhere in the New York City area. Importantly, our microbiology laboratory evaluates all specimens sent for mycobacterial culture specifically for M. haemophilum by using X-factor strips and incubating at 301C. At another institution, where M. haemophilum is not aggressively pursued in the microbiology laboratory, many cases of M. haemophilum infection may be misclassified as 'culturenegative' and treated empirically for tuberculosis or NTM.
Allograft T-cell depletion and the alloSCT conditioning regimen are also potential factors underlying the NTM epidemiology at our center, although T-cell depletion was not statistically associated with NTM infection in our series (P ¼ 0.26). T-cell immunodeficiency is the predominant defect that predisposes to mycobacterial infection. Among patients with AIDS and a CD4 count less than 100/ml, approximately 20% will develop disseminated MAC annually in the absence of prophylaxis. Donor PPDreactive T-cells are known to persist in long-term survivors of conventional alloSCT. On the contrary, recipients of T-cell depleted allografts are unresponsive to PPD in the absence of BCG or tuberculosis exposure. 27 This presumably results from the removal of T-cells that protect against NTM during depletion as well as the use of ATG as prophylaxis against graft rejection. In addition, TBI is lymphotoxic and impairs alveolar macrophage function in alloSCT recipients. 28 In the present series, 12 (75%) of the 16 patients with definite NTM infection received TBI and a T-cell depleted alloSCT, and 11 received ATG. All six patients with cutaneous M. haemophilum infection received TBI, which may predispose to cutaneous NTM infection by damaging immune effector cells in the skin. Finally, flouroquinolone prophylaxis is not routinely used prior to or during alloSCT at our centre. Flouroquinolones have activity against a broad range of mycobacteria and could affect the epidemiology of mycobacterial infection after alloSCT.
The high rates of probable or possible NTM infection in our series may have resulted from an ascertainment bias. A limited number of definite NTM infections over the past decade has heightened awareness of NTM as potential pathogens within our institution, increasing the number of mycobacterial cultures obtained from acutely ill patients with unexplained pulmonary or gastrointestinal abnormalities. These patients may be colonized with NTM such as MAC. Since these patients had an acute illness that prompted the collection of mycobacterial cultures, it is not surprising that their overall prognosis (Figure 2a) was poor, and their prognosis after first positive mycobacterial culture was dismal (Figure 2b) . None of the patients with probable or possible infection died from NTM infection, supporting the conclusion that NTM were colonizers or secondary pathogens among these patients. Unlike patients with definite NTM infection, those with probable or possible infection almost all had MAC and commonly had predisposing factors to colonization including underlying pulmonary disease, GVHD, and/or a history of chest irradiation. Survival among patients with definite infection was surprisingly good, at least in part because of the excellent prognosis of patients with cutaneous M. haemophilum infection (Figure 2c) . Disseminated MAC infection (as occurred in patient #13) has been extensively described in patients with AIDS 25, 29 but is surprisingly uncommon among alloSCT recipients. To our knowledge, only two cases of disseminated MAC among alloSCT recipients have previously been reported; both were children with congenital immunodeficiency syndromes who received T-cell depleted alloSCT and subsequently developed GVHD requiring systemic immunosuppression. 1, 4 Unlike these two cases, patient #13 had no medical history before developing myelodysplastic syndrome 7 months prior to alloSCT. Mediport infection by MAC (patient #10) has not been previously reported.
At MSKCC, the approach to alloSCT recipients with a positive mycobacterial culture includes an Infectious Disease Service consultation and multiple cultures from the lung, gastrointestinal tract, and blood. Patients with definite evidence of invasive NTM infection (eg, bacteremia) are promptly treated. Patients who lack a compatible clinical syndrome are observed off antibiotics, while other potential processes and pathogens are excluded. For patients with multiple positive cultures from the lung or gastrointestinal tract, a compatible syndrome, and radiologic evidence of infection, the decision to treat is made based on the risk of observation off antibiotics. In our experience, most pulmonary infiltrates and diarrhea in patients with positive cultures for MAC are not caused by mycobacterial infection.
In summary, mycobacteria are unusually common colonizers and pathogens among allogeneic stem cell transplant recipients at our institution. A combination of host, environmental, nosocomial and historical factors may contribute to this epidemiology. Outcomes vary markedly among mycobacterial infections based on species and sites of infection. While the prognosis for some patients with positive mycobacterial cultures is poor, mortality primarily results from other causes. Table 2 Published case series of infection by nontuberculous mycobacteria (NTM) after allogeneic stem cell transplantation (alloSCT) 
